An observational study in Pancreatectomy; Hyperglycemia and Diabete Mellitus, sponsored by Seoul National University Hospital. Completed. Per ClinicalTrials.gov, last updated 2020-06-01.
Sponsored by Seoul National University Hospital · Observational
This is a single center observational study to assess alteration of glucose metabolism after pancreatectomy.
Biochemical markers of glucose metabolism including oral glucose tolerance tests, fasting blood glucose, insulin, glucagon and HbA1c were performed on patients receiving pancreatectomy (pancreaticoduodenectomy and distal pancreatectomy). Tests were done preoperatively, postoperatively at 3 months, and at 1 year. The primary endpoints were the incidence and risk factors of new-onset and worsened DM after each type of pancreatectomy.
699 studies on the registry are indexed under Hyperglycemia; 105 are open to participants now.
This study's enrollment of 224 is above the median of 100 across 155 observational studies indexed under Hyperglycemia.
Browse Hyperglycemia studies →Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
patients receiving partial pancreatectomy
Exclusion Criteria:
pancreaticoduodenectomy
Diagnostic Test: oral glucose tolerance test
distal pancreatectomy
Diagnostic Test: oral glucose tolerance test
incidence & risk factors of new-onset DM
incidence \& risk factors of new onset DM after pancreatectomy
Time frame: at 1 year
incidence & risk factors of worsened DM
incidence \& risk factors of worsened DM after pancreatectomy
Time frame: at 1 year
characteristics of new-onset and worsened DM
changes of glucose metabolism during study period
Time frame: 1 year
No study locations are listed for this record.
Plan to share: No — There are no plans of sharing IPD
This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital